Fully 1,600 cancer treatments and vaccines are in development, according to speakers at an AMCP Nexus 2024 presentation, in Las Vegas. The median cost for new oncology drugs in 2023 was $298,628, they noted, adding that 72% of newly initiated trials in 2023 were for rare cancers and 82% were of potential treatments for solid tumors.
This is an exciting time for oncology therapeutics, said Kaelyn Boss, PharmD, a clinical consultant pharmacist at the University of Massachusetts Chan Medical